These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Calcium channel blockers. Dipalma JR Am Fam Physician; 1983 Feb; 27(2):283-5. PubMed ID: 6829383 [No Abstract] [Full Text] [Related]
6. Pharmacokinetics of calcium channel blocking agents. Anderson P Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():43-57. PubMed ID: 2940799 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of nicardipine following oral and intravenous administration in man. Graham DJ; Dow RJ; Freedman D; Mroszczak E; Ling T Postgrad Med J; 1984; 60 Suppl 4():7-10. PubMed ID: 6527979 [TBL] [Abstract][Full Text] [Related]
8. Disposition kinetics and urinary excretion of verapamil and some of its primary metabolites after oral administration in patients with angina pectoris. Piotrovskii VK; Rumiantsev DO; Nikolenko SA; Riabokon OS; Metelitsa VI Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):4-11. PubMed ID: 3957489 [TBL] [Abstract][Full Text] [Related]
10. [Clinical pharmacology of calcium inhibitors]. Singlas E; Martre H; Taburet AM Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():15-22. PubMed ID: 3937500 [TBL] [Abstract][Full Text] [Related]
11. Calcium channel blockers: verapamil and nifedipine. Foster BC Crit Care Update; 1983 Sep; 10(9):46-9. PubMed ID: 6555082 [No Abstract] [Full Text] [Related]
12. Clinical application of the pharmacokinetics of procaine amide. Koch-Weser J Cardiovasc Clin; 1974; 6(2):63-75. PubMed ID: 4613464 [No Abstract] [Full Text] [Related]
13. Effects of hemodynamic changes on the elimination kinetics of verapamil and nifedipine. Hamann SR; Blouin RA; Chang SL; Kaltenborn KE; Tan TG; McAllister RG J Pharmacol Exp Ther; 1984 Nov; 231(2):301-5. PubMed ID: 6491984 [TBL] [Abstract][Full Text] [Related]
14. Effect of atorvastatin on the intravenous and oral pharmacokinetics of verapamil in rats. Choi DH; Chang KS; Hong SP; Choi JS; Han HK Biopharm Drug Dispos; 2008 Jan; 29(1):45-50. PubMed ID: 17941000 [TBL] [Abstract][Full Text] [Related]
15. [Nifedipine in the treatment of diseases of the circulatory organs (a review of the literature)]. RevutskiÄ EL; Konopleva LF; Shevchuk SG Vrach Delo; 1989 Nov; (11):62-7. PubMed ID: 2692292 [No Abstract] [Full Text] [Related]
16. [The effect of calcium antagonists on the development of inflammatory edema in rats]. Briukhanov VM; Zverev IaF; Elkin VI Eksp Klin Farmakol; 1994; 57(2):47-9. PubMed ID: 8205050 [TBL] [Abstract][Full Text] [Related]
17. Calcium-channel antagonists in cardiovascular disease. Holdright DR Br J Hosp Med; 1997 Jun 4-17; 57(11):552-6. PubMed ID: 9307671 [TBL] [Abstract][Full Text] [Related]
18. Oral ethanol ingestion altered nifedipine pharmacokinetics in the rat: a preliminary study. Boje KM; Dolce JA; Fung HL Res Commun Chem Pathol Pharmacol; 1984 Nov; 46(2):219-26. PubMed ID: 6515116 [TBL] [Abstract][Full Text] [Related]
19. [Relationship between the pharmacokinetics of verapamil and its electrocardiographic effects]. Koike Y Hokkaido Igaku Zasshi; 1983 Jan; 58(1):17-29. PubMed ID: 6840665 [No Abstract] [Full Text] [Related]
20. Calcium channel blockers. New treatment for cardiovascular disease. Rossi LP; Antman EM Am J Nurs; 1983 Mar; 83(3):382-7. PubMed ID: 6550460 [No Abstract] [Full Text] [Related] [Next] [New Search]